Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative genomics on Wnt9a orthologs.

Yuriko Katoh1, Masaru Katoh

  • 1M & M Medical BioInformatics, Hongo 113-0033, Japan.

Oncology Reports
|April 6, 2005
PubMed
Summary

Researchers identified and characterized the rat Wnt9a gene, finding high amino-acid conservation with other mammals but significant divergence in the 5'-flanking promoter region. This study provides the first report on rat Wnt9a and comparative Wnt9a genomics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Frontiers in molecular medicine·2025
Same author

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

International journal of molecular medicine·2024
Same author

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Frontiers in molecular medicine·2024
Same author

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Clinical and translational medicine·2024
Same author

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Nature reviews. Clinical oncology·2024
Same author

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Scientific reports·2024

Area of Science:

  • Genomics and Bioinformatics
  • Developmental Biology
  • Cancer Research

Background:

  • WNT signaling pathways are crucial in both embryonic development and cancer.
  • The WNT9A gene is implicated in human cancers and embryonic processes like chondrogenesis.
  • Paralogous WNT gene regions exist in the human genome, suggesting evolutionary relationships.

Purpose of the Study:

  • To identify and characterize the rat Wnt9a gene using bioinformatics.
  • To perform comparative genomics of Wnt9a orthologs across species.
  • To analyze the conservation of coding and regulatory regions of the Wnt9a gene.

Main Methods:

  • Bioinformatic analysis of genomic sequences to identify the rat Wnt9a gene.
  • Sequence alignment to determine amino acid identity with orthologs (mouse, human, chicken).
  • Comparative analysis of exonic and 5'-flanking promoter regions between human and rodent Wnt9a.

Main Results:

  • The rat Wnt9a gene was identified, consisting of four exons.
  • Rat Wnt9a protein showed high amino acid identity (100% mouse, 98.1% human, 82.5% chicken).
  • Exonic regions were conserved, but the 5'-flanking promoter region showed significant divergence between human and rodent Wnt9a, with no conserved transcription-factor-binding sites identified.

Conclusions:

  • The rat Wnt9a gene has been successfully identified and characterized.
  • High conservation of Wnt9a protein sequences contrasts with significant divergence in promoter regions between species.
  • This work represents the first report on rat Wnt9a and comparative genomics of Wnt9a orthologs, offering insights into gene regulation.

Related Experiment Videos